European Journal of Clinical Pharmacology

, Volume 29, Issue 6, pp 739–741 | Cite as

Single-dose quinidine treatment inhibits metoprolol oxidation in extensive metabolizers

  • T. Leemann
  • P. Dayer
  • U. A. Meyer
Short Communications


Oxidation Metoprolol Quinidine Extensive Metabolizers Quinidine Treatment 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Bertilsson L, Eichelbaum M, Mellström B, Säwe J, Schulz H-U, Sjöqvist F (1980) Nortriptyline and antipyrine clearance in relation to debrisoquine hydroxylation in man. Life Sci 27: 1673–1677Google Scholar
  2. Cooper RG, Evans DAP (1984) Oxidation polymorphism has clinical relevance. Lancet 2: 227Google Scholar
  3. Dayer P, Balant L, Courvoisier F, Küpfer A, Kubli A, Gorgia A, Fabre J (1982) The genetic control of bufuralol metabolism in man. Eur J Drug Metab Pharmacokinet 7: 73–77Google Scholar
  4. Dayer P, Gasser R, Gut J, Kronbach T, Robertz GM, Eichelbaum M, Meyer UA (1984) Characterization of a common genetic defect of cytochrome P-450 mediated function (debrisoquine-sparteine type polymorphism). Biochem Biophys Res Commun 125: 374–380Google Scholar
  5. Dayer P, Leemann T, Marmy A, Rosenthaler J (1985) Interindividual variation of beta-adrenoceptor blocking drugs plasma concentration and effect: influence of genetic status on behaviour of atenolol, bopindolol and metoprolol. Eur J Clin Pharmacol 28: 149–153Google Scholar
  6. Dengler HJ, Eichelbaum M (1977) Polymorphismen und Defekte des Arzneimittelstoffwechsels als Ursache toxischer Reaktionen. Arzneimittelforsch 27: 1836–1844Google Scholar
  7. Distlerath L, Guengerich FP (1984) Characterization of a human liver cytochrome P-450 involved in the oxidation of debrisoquine and other drugs by using antibodies raised to the analogous rat enzyme. Proc Natl Acad Sci USA 81: 7348–7352Google Scholar
  8. Gut J, Gasser R, Dayer P, Kronbach T, Catin T, Meyer UA (1984) Debrisoquine-type polymorphism of drug oxidation: purification from human liver of a cytochrome P-450 isozyme with high activity for bufuralol hydroxylation. FEBS Lett 173: 287–290Google Scholar
  9. Hori R, Okumura K, Inui KI, Yasuhara M, Yamada K, Sakurai T, Kawai C (1984) Quinidine-induced rise in ajmaline plasma concentration. J Pharm Pharmacol 36: 202–204Google Scholar
  10. Idle JR, Smith RL (1984) The debrisoquine hydroxylation gene: a gene of multiple consequence. In: Lemberger L, Reidenberg M (eds) Proceedings of the Second World Conference on Clinical Pharmacology and Therapeutics. ASPET, Bethesda, pp 148–164Google Scholar
  11. Leemann T, Dayer P, Balant L, Buri P (1984) Direct determination of R- and S-metoprolol in biological fluids by ion-pair-HPLC. Experientia 40: 647Google Scholar
  12. Lennard MS, Silas JH, Freestone S, Threvethick J (1982) Defective metabolism of metoprolol in poor hydroxylators of debrisoquine. Br J Clin Pharmacol 14: 301–303Google Scholar
  13. Lennard MS, Silas JH, Freestone S, Tucker GT, Ramsay LE, Woods HF (1983) Differential stereoselective metabolism of metoprolol in extensive and poor hydroxylators of debrisoquine. Br J Clin Pharmacol 16: 586P-587PGoogle Scholar
  14. Mahgoub A, Idle JR, Dring LG, Lancaster R, Smith RL (1977) Polymorphic hydroxylation of debrisoquine in man. Lancet 2: 584–586Google Scholar
  15. Meyer UA (1984) The clinical pharmacology of cytochrome P-450. In: Lemberger L, Reidenberg M (eds) Proceedings of the Second World Conference on Clinical Pharmacology and Therapeutics. ASPET, Bethesda, pp 331–341Google Scholar
  16. Otton SV, Inaba T, Kalow W (1984) Competitive inhibition of sparteine oxidation in human liver by beta-adrenoceptor antagonists and other cardiovascular drugs. Life Sci 34: 73–80Google Scholar
  17. Price-Evans D, Mahgoub A, Sloan TP, Idle JR, Smith RL (1980) A family and population study of the genetic polymorphism of debrisoquine oxidation in a white British population. J Med Genet 17: 102–105Google Scholar

Copyright information

© Springer-Verlag 1986

Authors and Affiliations

  • T. Leemann
    • 1
  • P. Dayer
    • 1
  • U. A. Meyer
    • 2
  1. 1.Department of MedicineUniversity HospitalGenevaSwitzerland
  2. 2.Department of PharmacologyBiocenter of the UniversityBaselSwitzerland

Personalised recommendations